eVisit, a telehealth platform enabling virtual care for hospitals and health systems, announced the completion of its $14 million Series A round led by TVC Capital, a software-focused growth equity fund, with participation from current investors Kickstart Seed Fund, University Growth Fund, and Jeremy Andrus.
According to the company, the virtual care platform serves more than 100 hospitals and health systems – including some healthcare enterprises in the U.S. – hosting hundreds of thousands of virtual visits and connecting providers and patients within the HIPAA-compliant eVisit platform enabling providers to deliver efficient and effective patient care.
The platform support all specialties and end-to-end technology that fully virtualizes every step of the care process, including activities such as scheduling, intake and waiting room management, the virtual visit itself, and payment and discharge – all grounded in government-grade security, seamless EHR integration, and leading analytics and reporting, according to the company.
“This funding will further eVisit’s rapid expansion within the telehealth industry by providing greater resources to our technology platform and customer care activities during this pivotal time for telehealth – in the ever-changing COVID-19 landscape and beyond. In addition to scaling our organization with exceptional talent, we plan to further enhance our marketing and sales outreach to support our focused go-to-market strategy. This new round is a testament to the collective confidence from these partners in our ability to power the virtual care strategies and execution for hospitals and health systems across North America.”
eVisit, founded in 2013, has raised $15 to date, including a $2 million funding round in 2017, from Kickstart Seed Fund, Arizona Founders Fund, and Jeremy Andrus. The company employs more than 50 people with an office in Mesa, Arizona.
Telemedicine companies in the first nine months of 2020 raised $3.3 billion in funding. TigerConnect, a healthcare communication, collaboration, and telemedicine platform, closed a $45 million Series D investment to fuel continued investment into its telehealth and workflow collaboration platform to meet surging demand.